Notably, complementing their primary tumour analysis with patient-derived xenografts indicated that platelet-derived growth factor receptor alpha (PDGFRA) and BMI1 are involved in maintaining the stem-like phenotype and therefore represent potential therapeutic targets in this inoperable and aggressive disease. The gene discussed is PDGFRA; the disease is neoplasm.